Arphra/Issuer/SYNGENE.BO

SYNGENE.BO

Syngene International Limited

HealthcareBiotechnologyININRCountry macro →

$441.05

Jun 02, 2026

AI Brief

Revenue · FY

$37.39B

Net income

$3.17B

FY 2026

EPS · diluted

$7.87

EBITDA

$9.79B

Explain this page

Arphra AIPlain-English read on Syngene International Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$441.05

Change

-5.30%

Period high

$482.50

Period low

$390.25

Period start

$465.752026-02-01

Through 2026-06-02

Peers

No peer list available for SYNGENE.BO.

Sector & industry today

Live

Sectors

Healthcare
+1.61%
Energy
+1.43%
Industrials
+1.36%
Real Estate
+1.06%
Financial Services
+0.75%
Consumer Defensive
+0.73%
Consumer Cyclical
+0.44%
Basic Materials
+0.22%
Utilities
-0.31%
Communication Services
-1.93%
Technology
-2.30%

Top industries (issuer's industry highlighted)

Biotechnology
-1.55%
Investment - Banking & Investment Services
-4.83%
Broadcasting
-4.29%
Software - Infrastructure
-4.26%
Electronic Gaming & Multimedia
-3.95%
Software - Application
-3.91%
Computer Hardware
-3.62%
Internet Content & Information
-3.52%
Financial - Mortgages
-3.43%
Information Technology Services
-3.43%
Rental & Leasing Services
+3.42%
Auto - Recreational Vehicles
+3.21%

Fair value

Football field →

Weighted blend

$125.28

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Total assets

$70.55B

Total debt

$4.58B

Cash & equiv

$8.33B

Operating CF

$9.55B

Free cash flow

$6.11B

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for SYNGENE.BO.

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$37.39B	$5.27B	$3.17B	$7.87	+8.47%